250 related articles for article (PubMed ID: 32548799)
1. Prognostic Value of Melanoma-Associated Antigen-A (MAGE-A) Gene Expression in Various Human Cancers: A Systematic Review and Meta-analysis of 7428 Patients and 44 Studies.
Poojary M; Jishnu PV; Kabekkodu SP
Mol Diagn Ther; 2020 Oct; 24(5):537-555. PubMed ID: 32548799
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-Analysis.
Zhang C; Xu J; Xue S; Ye J
Mol Diagn Ther; 2020 Oct; 24(5):523-536. PubMed ID: 32410110
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.
Yu M; Yongzhi H; Chen S; Luo X; Lin Y; Zhou Y; Jin H; Hou B; Deng Y; Tu L; Jian Z
Oncotarget; 2017 Jun; 8(26):43356-43367. PubMed ID: 28498810
[TBL] [Abstract][Full Text] [Related]
5. Clinical Value of Long Noncoding RNA HOTAIR as a Novel Biomarker in Digestive Cancers: A Meta-Analysis.
Zhang Y; Zhou Y; Xu T; Tian W; Yang C; Wang X; Zhong S; Ran Q; Yang H; Zhu S
Technol Cancer Res Treat; 2018 Jan; 17():1533034618756783. PubMed ID: 29444619
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of c-Jun activation domain-binding protein-1 in cancer: A systematic review and meta-analysis.
Shi D; Mu S; Hu B; Zhang S; Liu J; Zhang Z; Shao Z
J Cell Mol Med; 2021 Mar; 25(6):2750-2763. PubMed ID: 33550701
[TBL] [Abstract][Full Text] [Related]
7. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.
Sun S; Dong H; Yan T; Li J; Liu B; Shao P; Li J; Liang C
BMC Med Genet; 2020 Jun; 21(1):139. PubMed ID: 32600280
[TBL] [Abstract][Full Text] [Related]
8. High lncSNHG15 expression may predict poor cancer prognosis: a meta-analysis based on the PRISMA and the bio-informatics analysis.
Fang SX; Chen C; Guo Q; Ke XX; Lu HL; Xu G
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633324
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.
Xu Y; Wang C; Zhang Y; Jia L; Huang J
Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056
[TBL] [Abstract][Full Text] [Related]
10. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
11. MiR-20a, a novel promising biomarker to predict prognosis in human cancer: a meta-analysis.
Huang D; Peng Y; Ma K; Deng X; Tang L; Jing D; Shao Z
BMC Cancer; 2018 Nov; 18(1):1189. PubMed ID: 30497428
[TBL] [Abstract][Full Text] [Related]
12. MAGE-D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesis.
Germano S; Kennedy S; Rani S; Gleeson G; Clynes M; Doolan P; McDonnell S; Hughes L; Crown J; O'Driscoll L
Int J Cancer; 2012 May; 130(9):1991-2002. PubMed ID: 21618523
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis.
Zhao S; Zhu H; Jiao R; Wu X; Ji G; Zhang X
BMC Cancer; 2020 Jan; 20(1):77. PubMed ID: 32000704
[TBL] [Abstract][Full Text] [Related]
14. The expression of MAGE-C1 and MAGE-C2 in breast cancer and their clinical significance.
Hou S; Sang M; Zhao L; Hou R; Shan B
Am J Surg; 2016 Jan; 211(1):142-51. PubMed ID: 26321295
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and Prognostic Significance of PRAME Overexpression in Human Cancer: A Meta-Analysis.
Li J; Yin J; Zhong J; Yang Z; Tang A; Li S
Biomed Res Int; 2020; 2020():8828579. PubMed ID: 33381588
[TBL] [Abstract][Full Text] [Related]
16. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
[TBL] [Abstract][Full Text] [Related]
17. MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy.
Laban S; Giebel G; Klümper N; Schröck A; Doescher J; Spagnoli G; Thierauf J; Theodoraki MN; Remark R; Gnjatic S; Krupar R; Sikora AG; Litjens G; Grabe N; Kristiansen G; Bootz F; Schuler PJ; Brunner C; Brägelmann J; Hoffmann TK; Perner S
Oncotarget; 2017 Feb; 8(9):14719-14735. PubMed ID: 28146422
[TBL] [Abstract][Full Text] [Related]
18. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progression.
Binabaj MM; Soleimani A; Rahmani F; Avan A; Khazaei M; Fiuji H; Soleimanpour S; Ryzhikov M; Ferns GA; Bahrami A; Hassanian SM
Gene; 2019 Jul; 706():131-139. PubMed ID: 31055021
[TBL] [Abstract][Full Text] [Related]
20. Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis.
Zeng P; Chen MB; Zhou LN; Tang M; Liu CY; Lu PH
Sci Rep; 2016 Sep; 6():33658. PubMed ID: 27645103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]